MAPT and Alzheimer disease: Studies by Diling and colleagues [207] revealed that circNF1-419, via its interaction with adaptor protein 2 B1 (AP2B1), regulated inflammatory factors TNF-α and NF-κB, with a resultant downregulation of tau, phosphorylated tau, Aβ1-42, and APOE, delaying AD onset.